Cyanobactins from Cyanobacteria: Current Genetic and Chemical State of Knowledge.
Mar Drugs
; 13(11): 6910-46, 2015 Nov 13.
Article
en En
| MEDLINE
| ID: mdl-26580631
Cyanobacteria are considered to be one of the most promising sources of new, natural products. Apart from non-ribosomal peptides and polyketides, ribosomally synthesized and post-translationally modified peptides (RiPPs) are one of the leading groups of bioactive compounds produced by cyanobacteria. Among these, cyanobactins have sparked attention due to their interesting bioactivities and for their potential to be prospective candidates in the development of drugs. It is assumed that the primary source of cyanobactins is cyanobacteria, although these compounds have also been isolated from marine animals such as ascidians, sponges and mollusks. The aim of this review is to update the current knowledge of cyanobactins, recognized as being produced by cyanobacteria, and to emphasize their genetic clusters and chemical structures as well as their bioactivities, ecological roles and biotechnological potential.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Proteínas Bacterianas
/
Diseño de Fármacos
/
Cianobacterias
Límite:
Animals
/
Humans
Idioma:
En
Año:
2015
Tipo del documento:
Article